The invention discloses an application of a Gnai2
protein inhibitor in preparation of a
medicine for treating
diabetic nephropathy, and belongs to the technical field of biological
medicine, research shows that expression of Gnai2 in a
diabetic nephropathy sample is up-regulated and is in
positive correlation with a
renal injury index, after the Gnai2
gene is knocked out, lipophagy can be promoted,
lipid droplet deposition can be reduced, development of
diabetic nephropathy can be relieved, and the Gnai2
protein inhibitor can be used for treating diabetic
nephropathy. Overexpression of the Gnai2
gene can significantly inhibit lipophagy, promote
lipid droplet deposition and aggravate development of diabetic
nephropathy. The Gnai2
protein as a
drug target can be used for screening and discovering substances for preventing and treating the diabetic
nephropathy, and the Gnai2 protein inhibitor has a good application prospect in the aspect of preparing drugs for treating the diabetic nephropathy. According to the invention, the blank of'
lipid metabolism disorder 'research in the
pathogenesis of diabetic nephropathy is filled, and the normal form transformation of diabetic nephropathy from single
sugar control treatment to'
lipid metabolism-
inflammation /
fibrosis' multi-channel precise treatment is promoted.